Physician profile
Jeffrey Snow
NPI 1518926807
$8,429.37
in general payments reported to CMS, 2019-2025
23 companies · $984 in 2025
The $984 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,920 · 2020: $167 · 2021: $381 · 2022: $1,428 · 2023: $987 · 2024: $2,561 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912 · Education: $1,000 · Travel and Lodging: $885 · Consulting Fee: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,912.20 |
| Education | $1,000.00 |
| Travel and Lodging | $884.83 |
| Consulting Fee | $736.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,375.31 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $2,064.11 | 2022-2023 | Interstim |
| Stryker Corporation | $366.46 | 2021 | |
| Kerecis Limited | $328.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Boston Scientific Corporation | $328.31 | 2024-2025 | General - Therapies, Axonics, Lux-Dx Insertable Cardiac Monitor |
| Aroa Biosurgery Incorporated | $309.69 | 2022-2025 | |
| Access Pro Medical, LLC | $140.31 | 2025 | Matriderm |
| Cook Medical LLC | $125.48 | 2019 | |
| Axonics, INC. | $45.49 | 2024 | Axonics |
| Biotissue Holdings INC. | $33.72 | 2023 | |
| Acell, INC. | $33.27 | 2019-2020 | |
| Coloplast Corp | $29.92 | 2025 | |
| Coopersurgical, INC. | $27.21 | 2019 | |
| Baudax Bio INC. | $27.11 | 2020-2021 | |
| Davol INC. | $26.84 | 2023 | Bard 3dmax Mesh |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mckesson Medical-Surgical, INC. | $24.70 | 2024 | |
| Conmed Corporation | $24.33 | 2025 | Airseal |
| Ethicon US, LLC | $23.47 | 2023 | Echelon; Endopath, Echelon Circular |
| Abbott Laboratories | $23.20 | 2023 | Amplatzer Amulet |
| Takeda Pharmaceuticals U.S.A., INC. | $20.37 | 2023 | Gattex |
| Shire North American Group INC | $18.50 | 2019 | |
| Innovation Technologies INC | $17.58 | 2023 | Irrisept |
| Ferring Pharmaceuticals INC. | $15.06 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.